(Report ID: 27055) Drug interactions analysis of:
Cyclophosphamide, Taxotere, Doxorubicin Hcl, DecadronMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,639 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 165 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 27055 | Jan, 10, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Cyclophosphamide |
Taxotere |
Doxorubicin Hcl |
Decadron |
Results from eHealthMe: 165 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Hyperglycaemia | 1 (0.61%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Abdominal Pain | 3 (21.43%) |
2 | Bone Pain | 3 (21.43%) |
3 | Septic Shock | 3 (21.43%) |
4 | Intestinal Perforation | 3 (21.43%) |
5 | Nerve Block | 2 (14.29%) |
6 | Obstructive Airways Disorder | 2 (14.29%) |
7 | Osteitis | 2 (14.29%) |
8 | Osteomyelitis | 2 (14.29%) |
9 | Metastatic Neoplasm | 2 (14.29%) |
10 | Oral Surgery | 2 (14.29%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Cytoxan | 9 |
2 | Neulasta | 7 |
3 | Adriamycin Pfs | 5 |
4 | Aromasin | 4 |
5 | Fluorouracil | 4 |
6 | Arimidex | 3 |
7 | Aspirin | 3 |
8 | Ativan | 3 |
9 | Compazine | 3 |
10 | Zofran | 3 |
Death: 1 (0.61% of total reports)
Cancer: 5 (3.03% of total reports)
| Name | Count (% of total reports) |
1 | Neutropenia | 40 (24.24%) |
2 | Pyrexia | 20 (12.12%) |
3 | Dyspnoea | 18 (10.91%) |
4 | Pleural Effusion | 15 (9.09%) |
5 | Nausea | 15 (9.09%) |
6 | Chest Pain | 12 (7.27%) |
7 | Osteonecrosis | 12 (7.27%) |
8 | White Blood Cell Count Decreased | 12 (7.27%) |
9 | Cardiac Arrest | 12 (7.27%) |
10 | White Blood Cell Count Increased | 11 (6.67%) |
| Name | Count |
1 | Cytoxan | 87 |
2 | Adriamycin Pfs | 66 |
3 | Neupogen | 31 |
4 | Zofran | 31 |
5 | Neulasta | 29 |
6 | Kytril | 27 |
7 | Benadryl | 20 |
8 | Compazine | 18 |
9 | Ativan | 18 |
10 | Anzemet | 17 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
